Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


19.11.2018

1 Cancer Res
2 Childs Nerv Syst
3 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Neurooncol
3 Neuro Oncol
1 Neurosurgery


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cancer Res

  1. MA L, Lin K, Chang G, Chen Y, et al
    Aberrant activation of beta-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2.
    Cancer Res. 2018 Nov 13. pii: 0008-5472.CAN-18-1304.
    PubMed     Text format     Abstract available


    Childs Nerv Syst

  2. ABU ARJA MH, Stanek JR, Morales La Madrid AE, Lassaletta A, et al
    The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource.
    Childs Nerv Syst. 2018 Nov 14. pii: 10.1007/s00381-018-4000.
    PubMed     Text format     Abstract available

  3. KEBUDI R, Cakir FB, Bay SB, Gorgun O, et al
    Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
    Childs Nerv Syst. 2018 Nov 11. pii: 10.1007/s00381-018-4001.
    PubMed     Text format     Abstract available


    Int J Cancer

  4. SELIGER C, Gerken M, Leitzmann MF, Hau P, et al
    Reply to Lu: Connecting the dots between metformin and high-grade glioma.
    Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31990.
    PubMed     Text format    

  5. LU VM
    Connecting the dots between metformin and high-grade glioma.
    Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31987.
    PubMed     Text format    

  6. CORBETTA C, Di Ianni N, Bruzzone MG, Patane M, et al
    Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.
    Int J Cancer. 2018 Nov 12. doi: 10.1002/ijc.31985.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  7. CHERLOW JM, Shaw DW, Margraf LR, Bowers DC, et al
    Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase II Study XXXX.
    Int J Radiat Oncol Biol Phys. 2018 Nov 9. pii: S0360-3016(18)33951.
    PubMed     Text format     Abstract available


    J Neurooncol

  8. OLSSON A, Bouaoun L, Auvinen A, Feychting M, et al
    Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden.
    J Neurooncol. 2018 Nov 12. pii: 10.1007/s11060-018-03019.
    PubMed     Text format     Abstract available

  9. OUADAH NS, Lecomte A, Robidel F, Olsson A, et al
    Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats.
    J Neurooncol. 2018 Nov 12. pii: 10.1007/s11060-018-03012.
    PubMed     Text format     Abstract available


    Neuro Oncol

  10. SCHIFF D, de Groot JF
    Lower-grade gliomas: the wrong target for bevacizumab.
    Neuro Oncol. 2018;20:1559-1560.
    PubMed     Text format    

  11. SPERDUTO PW, Deegan BJ, Li J, Jethwa KR, et al
    Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.
    Neuro Oncol. 2018;20:1652-1660.
    PubMed     Text format     Abstract available

  12. EISEMANN T, Costa B, Harter PN, Wick W, et al
    Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.
    Neuro Oncol. 2018 Nov 10. pii: 5168873. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery

  13. HENDRIKS EJ, Idema S, Hervey-Jumper SL, Bernat AL, et al
    Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map.
    Neurosurgery. 2018 Nov 10. pii: 5178544. doi: 10.1093.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: